Alopecia Areata

8 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Alopecia

Treatments and conditions

Alopecia Areata
Treatment and conditionWhere it standsTrials
Baricitinib for alopecia areataTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Deuruxolitinib for alopecia areataPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo for alopecia areataPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo - 100 mg + Ritlecitinib 50 mg for alopecia areataPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo - 50 mg + Ritlecitinib 100 mg for alopecia areataPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo + Upadacitinib for alopecia areataPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ritlecitinib 100 mg for alopecia areataPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Upadacitinib for alopecia areataPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.